Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001228684-26-000002

Director sold 12,500 shares at an average $68.79 ($859,819)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LINK WILLIAM J PHD Director 2026-03-16 Sale 10b5-1 −3,629 $68.09 $247,099 125,203 D
LINK WILLIAM J PHD Director 2026-03-16 Sale 10b5-1 −8,378 $69.03 $578,333 116,825 D
LINK WILLIAM J PHD Director 2026-03-16 Sale 10b5-1 −493 $69.75 $34,387 116,332 D
Open-market sales · 12,500 sh · avg $68.79 · $859,819
Loading xslF345X06/wk-form4_1773864674.xml…